These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3008117)

  • 21. Synthesis of carboxyl-terminal extension analogs of dermorphin and evaluation of their opioid receptor-binding and opioid activities.
    Ambo A; Sasaki Y; Suzuki K
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):888-91. PubMed ID: 7912660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central and peripheral components of dermorphin's effect on rat intestinal propulsion in comparison to morphine.
    Parolaro D; Sala M; Crema G; Spazzi L; Cesana R; Gori E
    Peptides; 1983; 4(1):55-8. PubMed ID: 6866810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loperamide binding to opiate receptor sites of brain and myenteric plexus.
    Mackerer CR; Clay GA; Dajani EZ
    J Pharmacol Exp Ther; 1976 Oct; 199(1):131-40. PubMed ID: 10422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kentsin: tetrapeptide from hamster embryos produces naloxone-sensitive effects without binding to opioid receptors.
    Fox DA; Ayres EA; Wire WS; Lui G; Yamamura HI; Burks TF
    Peptides; 1987; 8(4):613-8. PubMed ID: 2819832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and characterization of site-directed antibodies against dermorphin and dermorphin-related peptides.
    Cucumel K; Garreau I; Mery J; Moinier D; Mansour A; Akil H; Cupo A
    Peptides; 1996; 17(6):973-82. PubMed ID: 8899816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
    Sakurada S; Chaki K; Watanabe H; Nakata N; Sakurada T; Kisara K; Suzuki K
    J Pharmacol Exp Ther; 1992 Nov; 263(2):793-9. PubMed ID: 1331414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.
    Parolaro D; Sala M; Crema G; Spazzi L; Gori E
    Life Sci; 1983; 33 Suppl 1():485-8. PubMed ID: 6664230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermorphin interaction with rat brain opioid receptors: involvement of hydrophobic sites in the binding domain.
    Lazarus LH; Wilson WE; Guglietta A; de Castiglione R
    Mol Pharmacol; 1990 Jun; 37(6):886-92. PubMed ID: 2163014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate receptor mediation of ketamine analgesia.
    Finck AD; Ngai SH
    Anesthesiology; 1982 Apr; 56(4):291-7. PubMed ID: 6278991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.
    Tomatis R; Marastoni M; Balboni G; Guerrini R; Capasso A; Sorrentino L; Santagada V; Caliendo G; Lazarus LH; Salvadori S
    J Med Chem; 1997 Aug; 40(18):2948-52. PubMed ID: 9288177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New models for the evaluation of opioid effects in the guinea-pig ileum.
    Donnerer J; Lembeck F
    Br J Pharmacol; 1985 May; 85(1):61-4. PubMed ID: 2992655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.
    Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1978 Dec; 64(4):607-14. PubMed ID: 215262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo opioid activity of [DPro(6)]dermorphin, a new dermorphin analogue.
    Broccardo M; Usenko AB; Uranova MG; Guzevatykh LS; Kamensky AA; Andreeva LA; Alfeeva LY; Myasoedov NF; Giannini E; Improta G; Emel'yanova TG
    Peptides; 2003 Mar; 24(3):419-28. PubMed ID: 12732340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
    Negri L; Lattanzi R; Melchiorri P
    Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermorphins, opioid peptides from amphibian skin, act on opioid receptors of mouse neuroblastoma x rat glioma hybrid cells.
    Glaser T; Hübner K; de Castiglione R; Hamprecht B
    J Neurochem; 1981 Dec; 37(6):1613-7. PubMed ID: 6278080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic tetrapeptides related to dermorphin: potent long lasting analgesic action following subcutaneous administration.
    Salvadori S; Marastoni M; Balboni G; degli Uberti E; Tomatis R
    Peptides; 1985; 6 Suppl 3():127-9. PubMed ID: 3831956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous opioid peptides: multiple agonists and receptors.
    Lord JA; Waterfield AA; Hughes J; Kosterlitz HW
    Nature; 1977 Jun; 267(5611):495-9. PubMed ID: 195217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization.
    Massi P; Giagnoni G; Basilico L; Gori E; Rubino T; Parolaro D
    Eur J Pharmacol; 1994 Mar; 253(3):269-74. PubMed ID: 8200420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
    Negri L; Lattanzi R; Tabacco F; Melchiorri P
    Br J Pharmacol; 1998 May; 124(2):345-55. PubMed ID: 9641552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid peptides. Synthesis and binding assays of desamino-Tyr1 dermorphin analogues. XII.
    Salvadori S; Marastoni M; Balboni G; Tomatis R; Borea PA
    Farmaco Sci; 1987 Dec; 42(12):931-40. PubMed ID: 2896601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.